HUMAN IMMUNODEFICIENCY VIRUS TYPE I AS A TARGET FOR GENE THERAPY

Magnús Gottfredsson and Paul R. Bohjanen

Division of Infectious Diseases and International Health, Department of Medicine, Duke University Medical Center, Durham, NC 27710

Received 11/17/97 Accepted 11/24/97

7. ACKNOWLEDGMENTS

The authors thank C. Smith, B. Sullenger, M. Garcia-Blanco, and C. Suñé for helpful discussions regarding HIV-1 biology and gene therapy. MG is supported in part by a NATO science fellowship and PRB is supported by a Howard Hughes Medical Institute postdoctoral fellowship for physicians.